[T]he Trump administration wins again. This time the US Court of Appeals upheld a federal Circuit Court victory for the Pentagon’s new policy to have service members serve in the sex they were assigned at birth.
Since 2016 when former President Obama led the charge for LGBT changes to existing military procedures, there has been much debate over the fitness for transgender individuals to serve in the U.S. military.
The Department of the Defense and the President rightly note that this process also bears a tax-payer expense that could be avoided if the sex-change were done prior to their military service at their own personal expense.
After April 12, no one with gender dysphoria who is taking hormones or has transitioned to another gender will be allowed to enlist.
According to MilitaryTimes.com: “Under the new rules, currently serving transgender troops and anyone who has signed an enlistment contract by April 12 may continue with plans for hormone treatments and gender transition if they have been diagnosed with gender dysphoria.
But after April 12, no one with gender dysphoria who is taking hormones or has transitioned to another gender will be allowed to enlist. And any currently serving troops diagnosed with gender dysphoria after April 12 will have to serve in their birth gender and will be barred from taking hormones or getting transition surgery.”
Military service members diagnosed with Gender Dysphoria (GD), previously known as Gender Identity Disorder (GID), require extended medical leave for such transitioning. This absenteeism puts military men and women on the frontlines at risk of being understaffed on base and in the battlefield, rendering them vulnerable as a result.